Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Video Interview: Q BioMed Accelerates Advances In Vascular Therapeutics

This article was originally published in Scrip

Executive Summary

Ensuring that all the necessary resources are in place to build a sustainable business is a key challenge for most entrepreneurs. They need access to capital and expertise without having to give it away cheaply. Q BioMed Inc CEO Denis Corin explains to Mike Ward, global director of content for Informa's pharma insight products, how his biomedical acceleration and development company is providing target companies and assets access to strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst